HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
111738.0,207547,2166-11-07 06:49:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Clopidogrel 75 mg daily
   ASA 325mg
   Atorvostatin 80mg daily
   Metoprolol 37.5mg TID
   Warfarin 2mg daily
   Senna
   Docusate
   Exelon
   Namenda
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-7**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 78 (58 - 78) bpm
   BP: 147/77(95) {100/41(56) - 147/78(95)} mmHg
   RR: 14 (10 - 20) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                    438 mL
                                                                    500 mL
   PO:
                                                                    350 mL
             TF:
   IVF:
                                                                     88 mL
                                                                    500 mL
   Blood products:
   Total out:
                                                                    550 mL
                                                                    400 mL
   Urine:
                                                                    550 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -112 mL
                                                                    100 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   GENERAL: NAD. Oriented x2. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. mild crackles at the bases no
   wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.
   SKIN: No venoous stasis changes ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ PT 1+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   487 K/uL
   12.6 g/dL
   103 mg/dL
   1.0 mg/dL
   25 mEq/L
   5.0 mEq/L
   17 mg/dL
   109 mEq/L
   142 mEq/L
   37.9 %
   10.0 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
   WBC
   10.0
   Hct
   37.9
   Plt
   406
   487
   Cr
   1.0
   TropT
   1.00
   Glucose
   103
   Other labs: PT / PTT / INR:29.2/29.7/2.9, CK / CKMB /
   Troponin-T:247/17/1.00, Ca++:7.9 mg/dL, Mg++:1.8 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   .
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Pt currently CP free.
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - holding ACEI given Cr 1.3 and unknown baseline. Will trend and
   restart in AM if Cr stable
   - trend CE
   - TTE in AM
   - ECG in AM
   - monitor on tele
   - post-cath check tonight
   .
   # PUMP: euvolemic on exam
   - TTE in AM
   - consider restarting ACEI
   .
   # RHYTHM: sinus
   - monitor on tele
   .
   # Hyperkalemia: K was 5.6 on admission and sample not hemolyzed. ECG no
   changes concerning for hyperkalemia.
   - recheck K
   - kayexalate x1
   - monitor on tele
   .
   # CRI: Unclear baseline and whether this is an acute change. Likely
   chronic given history of HTN.
   - holding ACEI for now and will restart in AM if stable
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   .
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   .
   # Dementia: pt at baseline
   - cont home meds
   .
   FEN: Cardiac
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   .
   CODE: FULL- confirmed with wife
   .
   COMM: Wife: [**Telephone/Fax (1) 12064**]
   .
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Clopidogrel 75 mg daily
   ASA 325mg
   Atorvostatin 80mg daily
   Metoprolol 37.5mg TID
   Warfarin 2mg daily
   Senna
   Docusate
   Exelon
   Namenda
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-7**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 78 (58 - 78) bpm
   BP: 147/77(95) {100/41(56) - 147/78(95)} mmHg
   RR: 14 (10 - 20) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                    438 mL
                                                                    500 mL
   PO:
                                                                    350 mL
             TF:
   IVF:
                                                                     88 mL
                                                                    500 mL
   Blood products:
   Total out:
                                                                    550 mL
                                                                    400 mL
   Urine:
                                                                    550 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -112 mL
                                                                    100 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   GENERAL: NAD. Oriented x2. Mood, affect appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. mild crackles at the bases no
   wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.
   SKIN: No venoous stasis changes ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ PT 1+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   487 K/uL
   12.6 g/dL
   103 mg/dL
   1.0 mg/dL
   25 mEq/L
   5.0 mEq/L
   17 mg/dL
   109 mEq/L
   142 mEq/L
   37.9 %
   10.0 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
   WBC
   10.0
   Hct
   37.9
   Plt
   406
   487
   Cr
   1.0
   TropT
   1.00
   Glucose
   103
   Other labs: PT / PTT / INR:29.2/29.7/2.9, CK / CKMB /
   Troponin-T:247/17/1.00, Ca++:7.9 mg/dL, Mg++:1.8 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   .
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Pt currently CP free.
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - holding ACEI given Cr 1.3 and unknown baseline. Will trend and
   restart in AM if Cr stable
   - trend CE
   - TTE in AM
   - ECG in AM
   - monitor on tele
   - post-cath check tonight
   .
   # PUMP: euvolemic on exam
   - TTE in AM
   - consider restarting ACEI
   .
   # RHYTHM: sinus
   - monitor on tele
   .
   # Hyperkalemia: K was 5.6 on admission and sample not hemolyzed. ECG no
   changes concerning for hyperkalemia.
   - recheck K
   - kayexalate x1
   - monitor on tele
   .
   # CRI: Unclear baseline and whether this is an acute change. Likely
   chronic given history of HTN.
   - holding ACEI for now and will restart in AM if stable
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   .
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   .
   # Dementia: pt at baseline
   - cont home meds
   .
   FEN: Cardiac
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   .
   CODE: FULL- confirmed with wife
   .
   COMM: Wife: [**Telephone/Fax (1) 12064**]
   .
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided medical progress note, the patient is an 88-year-old male with a significant past medical history of hypertension, stroke, and deep vein thrombosis (DVT) on coumadin. He presented with an acute anterior ST-elevation myocardial infarction (STEMI) and was taken to the catheterization laboratory for percutaneous coronary intervention (PCI) with a bare-metal stent (BMS) placed in the mid-left anterior descending (LAD) artery. 

The patient's current vital signs are within normal limits, with a temperature of 37.4°C, heart rate of 78 beats per minute, and blood pressure of 147/77 mmHg. His respiratory rate is 14 breaths per minute, and oxygen saturation is 98% on nasal cannula. His physical examination is notable for a normal cardiac examination, mild crackles at the bases of the lungs, and soft, non-tender abdomen.

Laboratory results show mild hyperkalemia (5.0 mEq/L), and the patient is being monitored closely for this. His complete blood count (CBC) and comprehensive metabolic panel (CMP) are within normal limits, except for a slightly elevated creatinine (1.0 mg/dL). His troponin-T is elevated at 1.00 ng/mL.

The patient's medications include aspirin, clopidogrel, atorvastatin, metoprolol, warfarin, senna, docusate, Exelon, and Namenda. He is also receiving infusions of antibiotics and other ICU medications.

Potential medical complications that can arise from this patient's condition include:

1. Cardiac arrhythmias: The patient's history of hypertension and STEMI puts him at risk for cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia.
2. Heart failure: The patient's history of hypertension and STEMI also increases his risk for heart failure, which can lead to pulmonary edema and decreased cardiac output.
3. Renal insufficiency: The patient's elevated creatinine level and history of hypertension increase his risk for renal insufficiency, which can lead to electrolyte imbalances and decreased renal function.
4. Hyperkalemia: The patient's mild hyperkalemia requires close monitoring, as high levels of potassium can lead to cardiac arrhythmias and decreased cardiac output.
5. Bleeding complications: The patient's use of anticoagulant medications, such as warfarin and clopidogrel, increases his risk for bleeding complications, such as gastrointestinal bleeding or intracranial hemorrhage.
6. DVT and pulmonary embolism: The patient's history of DVT and use of anticoagulant medications increases his risk for recurrent DVT and pulmonary embolism.
7. Infection: The patient's use of antibiotics and other ICU medications increases his risk for infection, such as ventilator-associated pneumonia (VAP).

Based on this patient's condition and potential complications, close monitoring and management are necessary to prevent and treat these complications and ensure the patient's overall well-being."
111738.0,207547,2166-11-07 06:49:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   This morning, complained of persistent back, shoulder discomfort with
   chest tightness.  EKG showed evolving ST changes in anterior leads and
   patient hyperadrenergic with elevated heart rate and blood pressure.
   Started transiently on nitro gtt until pain resolved.  After developed
   marginal blood pressure with SBP in 80s.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Clopidogrel 75 mg daily
   ASA 325mg
   Atorvostatin 80mg daily
   Metoprolol 37.5mg TID
   Warfarin 2mg daily
   Senna
   Docusate
   Exelon
   Namenda
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-7**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 78 (58 - 78) bpm
   BP: 147/77(95) {100/41(56) - 147/78(95)} mmHg
   RR: 14 (10 - 20) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                    438 mL
                                                                    500 mL
   PO:
                                                                    350 mL
             TF:
   IVF:
                                                                     88 mL
                                                                    500 mL
   Blood products:
   Total out:
                                                                    550 mL
                                                                    400 mL
   Urine:
                                                                    550 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -112 mL
                                                                    100 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   GENERAL: NAD. Oriented x2. Appears anxious.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. S4. No m/r/g. No thrills, lifts.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. mild crackles at the bases no
   wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.
   SKIN: No venoous stasis changes ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ PT 1+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   487 K/uL
   12.6 g/dL
   103 mg/dL
   1.0 mg/dL
   25 mEq/L
   5.0 mEq/L
   17 mg/dL
   109 mEq/L
   142 mEq/L
   37.9 %
   10.0 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
   WBC
   10.0
   Hct
   37.9
   Plt
   406
   487
   Cr
   1.0
   TropT
   1.00
   Glucose
   103
   Other labs: PT / PTT / INR:29.2/29.7/2.9, CK / CKMB /
   Troponin-T:247/17/1.00, Ca++:7.9 mg/dL, Mg++:1.8 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   .
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - trend CE
   - TTE in AM
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   .
   # PUMP: euvolemic on exam
   - TTE in AM
   - restart ACEI
   .
   # RHYTHM: sinus
   - monitor on tele
   .
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   .
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   .
   # Dementia: pt at baseline
   - cont home meds
   .
   FEN: Cardiac
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   .
   CODE: FULL- confirmed with wife
   .
   COMM: Wife: [**Telephone/Fax (1) 12064**]
   .
   DISPO: CCU for now
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   This morning, complained of persistent back, shoulder discomfort with
   chest tightness.  EKG showed evolving ST changes in anterior leads and
   patient hyperadrenergic with elevated heart rate and blood pressure.
   Started transiently on nitro gtt until pain resolved.  After developed
   marginal blood pressure with SBP in 80s.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Clopidogrel 75 mg daily
   ASA 325mg
   Atorvostatin 80mg daily
   Metoprolol 37.5mg TID
   Warfarin 2mg daily
   Senna
   Docusate
   Exelon
   Namenda
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-7**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 78 (58 - 78) bpm
   BP: 147/77(95) {100/41(56) - 147/78(95)} mmHg
   RR: 14 (10 - 20) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                    438 mL
                                                                    500 mL
   PO:
                                                                    350 mL
             TF:
   IVF:
                                                                     88 mL
                                                                    500 mL
   Blood products:
   Total out:
                                                                    550 mL
                                                                    400 mL
   Urine:
                                                                    550 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -112 mL
                                                                    100 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   GENERAL: NAD. Oriented x2. Appears anxious.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. S4. No m/r/g. No thrills, lifts.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. mild crackles at the bases no
   wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.
   SKIN: No venoous stasis changes ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ PT 1+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   487 K/uL
   12.6 g/dL
   103 mg/dL
   1.0 mg/dL
   25 mEq/L
   5.0 mEq/L
   17 mg/dL
   109 mEq/L
   142 mEq/L
   37.9 %
   10.0 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
   WBC
   10.0
   Hct
   37.9
   Plt
   406
   487
   Cr
   1.0
   TropT
   1.00
   Glucose
   103
   Other labs: PT / PTT / INR:29.2/29.7/2.9, CK / CKMB /
   Troponin-T:247/17/1.00, Ca++:7.9 mg/dL, Mg++:1.8 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   .
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - trend CE
   - TTE in AM
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   .
   # PUMP: euvolemic on exam
   - TTE in AM
   - restart ACEI
   .
   # RHYTHM: sinus
   - monitor on tele
   .
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   .
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   .
   # Dementia: pt at baseline
   - cont home meds
   .
   FEN: Cardiac
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   .
   CODE: FULL- confirmed with wife
   .
   COMM: Wife: [**Telephone/Fax (1) 12064**]
   .
   DISPO: CCU for now<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 88-year-old male with a history of hypertension, stroke, and deep vein thrombosis (DVT) on warfarin, who presented with anterior ST-elevation myocardial infarction (STEMI) and was taken to the catheterization laboratory for percutaneous coronary intervention (PCI) with placement of a bare-metal stent in the mid-left anterior descending (LAD) artery. The patient had recurrent pain, which was likely post-infarct discomfort rather than recurrent ischemia. The patient is currently being managed with aspirin, clopidogrel, atorvastatin, metoprolol, warfarin, and senna.

Potential Medical Complications:

1. Recurrent Ischemia: Despite the PCI, the patient may still be at risk for recurrent ischemia, particularly if there are residual lesions in the coronary arteries.
2. Heart Failure: The patient's ejection fraction is not specified, but the presence of anterior STEMI and the patient's age may increase the risk of heart failure.
3. Cardiac Rhythm Disturbances: The patient is currently in sinus rhythm, but may be at risk for atrial fibrillation or other cardiac rhythm disturbances, particularly with the use of metoprolol.
4. Renal Dysfunction: The patient's creatinine level is 1.0 mg/dL, which may indicate chronic kidney disease. The use of ACE inhibitors and other nephrotoxic medications may worsen renal function.
5. Bleeding Complications: The patient is taking warfarin and aspirin, which may increase the risk of bleeding complications, particularly in the setting of a recent PCI.
6. DVT and Pulmonary Embolism: The patient has a history of DVT and is currently taking warfarin, which may increase the risk of pulmonary embolism.
7. Infection: The patient is at risk for infection, particularly with the use of indwelling catheters and the presence of a recent PCI.
8. Medication-Related Adverse Effects: The patient is taking multiple medications, which may increase the risk of adverse effects, such as gastrointestinal bleeding with aspirin and clopidogrel, or liver dysfunction with atorvastatin."
111738.0,207547,2166-11-07 06:49:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   This morning, complained of persistent back, shoulder discomfort with
   chest tightness.  EKG showed evolving ST changes in anterior leads and
   patient hyperadrenergic with elevated heart rate and blood pressure.
   Started transiently on nitro gtt until pain resolved.  After developed
   marginal blood pressure with SBP in 80s.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Clopidogrel 75 mg daily
   ASA 325mg
   Atorvostatin 80mg daily
   Metoprolol 37.5mg TID
   Warfarin 2mg daily
   Senna
   Docusate
   Exelon
   Namenda
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-7**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 78 (58 - 78) bpm
   BP: 147/77(95) {100/41(56) - 147/78(95)} mmHg
   RR: 14 (10 - 20) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                    438 mL
                                                                    500 mL
   PO:
                                                                    350 mL
             TF:
   IVF:
                                                                     88 mL
                                                                    500 mL
   Blood products:
   Total out:
                                                                    550 mL
                                                                    400 mL
   Urine:
                                                                    550 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -112 mL
                                                                    100 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   GENERAL: NAD. Oriented x2. Appears anxious.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. S4. No m/r/g. No thrills, lifts.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. mild crackles at the bases no
   wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.
   SKIN: No venoous stasis changes ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ PT 1+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   487 K/uL
   12.6 g/dL
   103 mg/dL
   1.0 mg/dL
   25 mEq/L
   5.0 mEq/L
   17 mg/dL
   109 mEq/L
   142 mEq/L
   37.9 %
   10.0 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
   WBC
   10.0
   Hct
   37.9
   Plt
   406
   487
   Cr
   1.0
   TropT
   1.00
   Glucose
   103
   Other labs: PT / PTT / INR:29.2/29.7/2.9, CK / CKMB /
   Troponin-T:247/17/1.00, Ca++:7.9 mg/dL, Mg++:1.8 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   .
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - trend CE
   - TTE in AM
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   .
   # PUMP: euvolemic on exam
   - TTE in AM
   - restart ACEI
   .
   # RHYTHM: sinus
   - monitor on tele
   .
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   .
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   .
   # Dementia: pt at baseline
   - cont home meds
   .
   FEN: Cardiac
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   .
   CODE: FULL- confirmed with wife
   .
   COMM: Wife: [**Telephone/Fax (1) 12064**]
   .
   DISPO: CCU for now
   ------ Protected Section ------
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) **].
   I would add the following remarks:
   History
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion. Cath showed and 80% hazy mid LAD lesion that was
   stented with a BMS. Additionally there was an 80% RI and 90% LCx and
   80% mid RCA lesion. He continued to have low grade chest pain overnight
   and is pain free this morning. CK up to 247 thus far. Hct, BUN and
   creat stable
   Medical Decision Making
   88 male here with anterior STEMI aborted with BMS to LAD. Patient has
   lesions in the RCA, RI and LCx which require intervention. Will
   increase Metoprolol to 37.5 [**Hospital1 7**] and ACEI as BP tolerates. He will
   remain on coumadin for h/o DVT/PE. Ok to floor later today. Continue to
   trend enzymes.
   Above discussed extensively with patient. I have discussed this plan
   with Dr(s). [**Name (NI) **] and Pride.
   Total time spent on patient care: 40 minutes of critical care time.
   ------ Protected Section Addendum Entered By:[**Name (NI) 861**] [**Last Name (NamePattern1) **], MD
   on:[**2166-11-7**] 07:59 PM ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   This morning, complained of persistent back, shoulder discomfort with
   chest tightness.  EKG showed evolving ST changes in anterior leads and
   patient hyperadrenergic with elevated heart rate and blood pressure.
   Started transiently on nitro gtt until pain resolved.  After developed
   marginal blood pressure with SBP in 80s.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Clopidogrel 75 mg daily
   ASA 325mg
   Atorvostatin 80mg daily
   Metoprolol 37.5mg TID
   Warfarin 2mg daily
   Senna
   Docusate
   Exelon
   Namenda
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-7**] 06:40 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.4
   HR: 78 (58 - 78) bpm
   BP: 147/77(95) {100/41(56) - 147/78(95)} mmHg
   RR: 14 (10 - 20) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
             Total In:
                                                                    438 mL
                                                                    500 mL
   PO:
                                                                    350 mL
             TF:
   IVF:
                                                                     88 mL
                                                                    500 mL
   Blood products:
   Total out:
                                                                    550 mL
                                                                    400 mL
   Urine:
                                                                    550 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -112 mL
                                                                    100 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   GENERAL: NAD. Oriented x2. Appears anxious.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 8 cm.
   CARDIAC: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. S4. No m/r/g. No thrills, lifts.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. mild crackles at the bases no
   wheezes or rhonchi.
   ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   EXTREMITIES: No c/c/e. No femoral bruits.
   SKIN: No venoous stasis changes ulcers, scars, or xanthomas.
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ PT 1+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   487 K/uL
   12.6 g/dL
   103 mg/dL
   1.0 mg/dL
   25 mEq/L
   5.0 mEq/L
   17 mg/dL
   109 mEq/L
   142 mEq/L
   37.9 %
   10.0 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
   WBC
   10.0
   Hct
   37.9
   Plt
   406
   487
   Cr
   1.0
   TropT
   1.00
   Glucose
   103
   Other labs: PT / PTT / INR:29.2/29.7/2.9, CK / CKMB /
   Troponin-T:247/17/1.00, Ca++:7.9 mg/dL, Mg++:1.8 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   .
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - trend CE
   - TTE in AM
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   .
   # PUMP: euvolemic on exam
   - TTE in AM
   - restart ACEI
   .
   # RHYTHM: sinus
   - monitor on tele
   .
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   .
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   .
   # Dementia: pt at baseline
   - cont home meds
   .
   FEN: Cardiac
   .
   ACCESS: PIV's
   .
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   .
   CODE: FULL- confirmed with wife
   .
   COMM: Wife: [**Telephone/Fax (1) 12064**]
   .
   DISPO: CCU for now
   ------ Protected Section ------
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) **].
   I would add the following remarks:
   History
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion. Cath showed and 80% hazy mid LAD lesion that was
   stented with a BMS. Additionally there was an 80% RI and 90% LCx and
   80% mid RCA lesion. He continued to have low grade chest pain overnight
   and is pain free this morning. CK up to 247 thus far. Hct, BUN and
   creat stable
   Medical Decision Making
   88 male here with anterior STEMI aborted with BMS to LAD. Patient has
   lesions in the RCA, RI and LCx which require intervention. Will
   increase Metoprolol to 37.5 [**Hospital1 7**] and ACEI as BP tolerates. He will
   remain on coumadin for h/o DVT/PE. Ok to floor later today. Continue to
   trend enzymes.
   Above discussed extensively with patient. I have discussed this plan
   with Dr(s). [**Name (NI) **] and Pride.
   Total time spent on patient care: 40 minutes of critical care time.
   ------ Protected Section Addendum Entered By:[**Name (NI) 861**] [**Last Name (NamePattern1) **], MD
   on:[**2166-11-7**] 07:59 PM ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 88-year-old male with a significant past medical history, including hypertension, stroke, and deep vein thrombosis (DVT) on coumadin. He was admitted with an acute anterior ST-segment elevation myocardial infarction (STEMI) and underwent percutaneous coronary intervention (PCI) with a bare-metal stent (BMS) to the mid-left anterior descending (LAD) lesion.

The patient's current condition is stable, with a heart rate of 78 beats per minute and a blood pressure of 147/77 mmHg. His respiratory rate is 14 breaths per minute, and his oxygen saturation is 98% on nasal cannula. His physical examination is significant for a supple neck, with a jugular venous pressure (JVP) of 8 cm.

Laboratory results show:

* White blood cell count: 10.0 K/uL
* Hematocrit: 37.9%
* Platelet count: 406 K/uL
* Creatinine: 1.0 mg/dL
* Troponin-T: 1.00 ng/mL
* Glucose: 103 mg/dL

The patient's medical plan includes:

* ASA 325mg daily
* Clopidogrel 75mg daily x 1 year
* Atorvastatin 80mg daily
* Metoprolol 37.5mg TID
* Warfarin 2mg daily
* Senna and docusate for bowel regimen
* Morphine and nitroglycerin as needed for pain management

Potential medical complications that may arise include:

* Recurrent ischemia or infarction
* Hypertension
* Dysrhythmias
* Congestive heart failure
* Kidney injury or failure
* Bleeding complications due to anticoagulation therapy
* Thrombotic events due to stent placement

It is essential to closely monitor the patient's condition, including his cardiac and renal function, as well as his bleeding and thrombotic risk. Frequent laboratory testing and imaging studies will be necessary to assess the patient's response to treatment and detect any potential complications."
111738.0,207547,2166-11-08 06:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - CP in AM, followed by increasing CK, peaked at 1147, MB at 113
   - ECHO: moderate regional LV systolic dysfxn with akinesis of the mid-
   and distal anterior wall and septum, apex and distal inferior segment
   (mid-LAD territory). LVEF = 35%
   - wasn't urinating, inserted foley
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2166-11-7**] 09:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-8**] 06:52 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 68 (61 - 100) bpm
   BP: 117/58(72) {85/42(58) - 165/87(104)} mmHg
   RR: 13 (12 - 24) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
                  Total In:
                                                                  2,726 mL
                                                                    120 mL
   PO:
                                                                  1,720 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  1,006 mL
   Blood products:
   Total out:
                                                                    875 mL
                                                                    450 mL
   Urine:
                                                                    875 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,851 mL
                                                                   -330 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///27/
   Physical Examination
   Gen: well appearing male, appears stated age
   Neck: JVD flat
   CV: RRR, Nl S1 S2. no mrg
   Lungs: clear to auscultation bilaterally.  No rales, wheezes, rhonchi.
   Abd: soft, ND, NT ABS
   Ext: wwp, palpable DP pulses
   Neuro: Alert and oriented to person
   Labs / Radiology
   510 K/uL
   12.2 g/dL
   107 mg/dL
   1.1 mg/dL
   27 mEq/L
   4.4 mEq/L
   20 mg/dL
   106 mEq/L
   140 mEq/L
   36.5 %
   11.1 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
                            [**2166-11-8**]  05:20 AM
   WBC
   10.0
   11.1
   Hct
   37.9
   36.5
   Plt
   [**Telephone/Fax (3) 12094**]
   Cr
   1.0
   1.1
   TropT
   1.00
   2.81
   Glucose
   103
   107
   Other labs: PT / PTT / INR:31.3/30.2/3.1, CK / CKMB /
   Troponin-T:731/44/2.81, Ca++:8.4 mg/dL, Mg++:1.9 mg/dL, PO4:2.6 mg/dL
   Imaging: ECHO:The left atrium is mildly dilated. There is mild
   symmetric left ventricular hypertrophy with normal cavity size. There
   is moderate regional left ventricular systolic dysfunction with
   akinesis of the mid- and distal anterior wall and septum, apex and
   distal inferior segment (mid-LAD territory). The remaining segments
   contract normally (LVEF = 35%). The LV apex is not visualized
   sufficiently for a thrombus to be definitely excluded, although one is
   not seen. Right ventricular chamber size and free wall motion are
   normal. The ascending aorta is mildly dilated. The aortic arch is
   mildly dilated. The aortic valve leaflets (3) are mildly thickened but
   aortic stenosis is not present. No aortic regurgitation is seen. The
   mitral valve leaflets are mildly thickened. Mild (1+) mitral
   regurgitation is seen. There is mild pulmonary artery systolic
   hypertension. There is no pericardial effusion.
   Microbiology: no new micro
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort.
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - start imdur 15mg today and uptitrate
   - morphine, nitro gtt, repeat EKG if pain recurs
   - intervention as outpt
   # PUMP: euvolemic on exam.
   - cont BB, ACEI, Imdur
   # RHYTHM: sinus
   - monitor on tele
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   # Dementia: pt at baseline
   - cont home meds
   FEN: Cardiac
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   CODE: FULL- confirmed with wife
   [**Name (NI) **]: Wife: [**Telephone/Fax (1) 12064**]
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) 2351**] and Pride.
   I would add the following remarks:
   Medical Decision Making
   CK peaked overnight at 1147 and the patient has no further chest pain.
   Echo shows mid to distal ant wall and septum are HK with EF 30-35% s/p
   LAD stenting for ASMI. He continue to have significant lesions in the
   LCx and RCA. He is intermittently confused and quite dysarthric. INR is
   3.1 to prevent mural thrombus. For CAD will continue ASA, Plavix, BB
   and Lisinopril 10 mg QD. Will add nitrates and plan to have the patient
   back in 1 month to stent the RCA and LCx. GI prophylaxis for coumadin,
   PLavix and ASA.
   Above discussed extensively with patient. I have discussed this plan
   with Dr(s). [**Name (NI) 2351**] and Pride.
   Total time spent on patient care: 40 minutes of critical care time.
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - CP in AM, followed by increasing CK, peaked at 1147, MB at 113
   - ECHO: moderate regional LV systolic dysfxn with akinesis of the mid-
   and distal anterior wall and septum, apex and distal inferior segment
   (mid-LAD territory). LVEF = 35%
   - wasn't urinating, inserted foley
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2166-11-7**] 09:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-8**] 06:52 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 68 (61 - 100) bpm
   BP: 117/58(72) {85/42(58) - 165/87(104)} mmHg
   RR: 13 (12 - 24) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
                  Total In:
                                                                  2,726 mL
                                                                    120 mL
   PO:
                                                                  1,720 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  1,006 mL
   Blood products:
   Total out:
                                                                    875 mL
                                                                    450 mL
   Urine:
                                                                    875 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,851 mL
                                                                   -330 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///27/
   Physical Examination
   Gen: well appearing male, appears stated age
   Neck: JVD flat
   CV: RRR, Nl S1 S2. no mrg
   Lungs: clear to auscultation bilaterally.  No rales, wheezes, rhonchi.
   Abd: soft, ND, NT ABS
   Ext: wwp, palpable DP pulses
   Neuro: Alert and oriented to person
   Labs / Radiology
   510 K/uL
   12.2 g/dL
   107 mg/dL
   1.1 mg/dL
   27 mEq/L
   4.4 mEq/L
   20 mg/dL
   106 mEq/L
   140 mEq/L
   36.5 %
   11.1 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
                            [**2166-11-8**]  05:20 AM
   WBC
   10.0
   11.1
   Hct
   37.9
   36.5
   Plt
   [**Telephone/Fax (3) 12094**]
   Cr
   1.0
   1.1
   TropT
   1.00
   2.81
   Glucose
   103
   107
   Other labs: PT / PTT / INR:31.3/30.2/3.1, CK / CKMB /
   Troponin-T:731/44/2.81, Ca++:8.4 mg/dL, Mg++:1.9 mg/dL, PO4:2.6 mg/dL
   Imaging: ECHO:The left atrium is mildly dilated. There is mild
   symmetric left ventricular hypertrophy with normal cavity size. There
   is moderate regional left ventricular systolic dysfunction with
   akinesis of the mid- and distal anterior wall and septum, apex and
   distal inferior segment (mid-LAD territory). The remaining segments
   contract normally (LVEF = 35%). The LV apex is not visualized
   sufficiently for a thrombus to be definitely excluded, although one is
   not seen. Right ventricular chamber size and free wall motion are
   normal. The ascending aorta is mildly dilated. The aortic arch is
   mildly dilated. The aortic valve leaflets (3) are mildly thickened but
   aortic stenosis is not present. No aortic regurgitation is seen. The
   mitral valve leaflets are mildly thickened. Mild (1+) mitral
   regurgitation is seen. There is mild pulmonary artery systolic
   hypertension. There is no pericardial effusion.
   Microbiology: no new micro
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort.
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - start imdur 15mg today and uptitrate
   - morphine, nitro gtt, repeat EKG if pain recurs
   - intervention as outpt
   # PUMP: euvolemic on exam.
   - cont BB, ACEI, Imdur
   # RHYTHM: sinus
   - monitor on tele
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   # Dementia: pt at baseline
   - cont home meds
   FEN: Cardiac
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   CODE: FULL- confirmed with wife
   [**Name (NI) **]: Wife: [**Telephone/Fax (1) 12064**]
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) 2351**] and Pride.
   I would add the following remarks:
   Medical Decision Making
   CK peaked overnight at 1147 and the patient has no further chest pain.
   Echo shows mid to distal ant wall and septum are HK with EF 30-35% s/p
   LAD stenting for ASMI. He continue to have significant lesions in the
   LCx and RCA. He is intermittently confused and quite dysarthric. INR is
   3.1 to prevent mural thrombus. For CAD will continue ASA, Plavix, BB
   and Lisinopril 10 mg QD. Will add nitrates and plan to have the patient
   back in 1 month to stent the RCA and LCx. GI prophylaxis for coumadin,
   PLavix and ASA.
   Above discussed extensively with patient. I have discussed this plan
   with Dr(s). [**Name (NI) 2351**] and Pride.
   Total time spent on patient care: 40 minutes of critical care time.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following summary and potential medical complications can be identified:

Summary:

The patient, an 88-year-old male, was admitted to the ICU with a diagnosis of anterior STEMI, s/p BMS to 80% mid-LAD lesion. He had a peak CK of 1147 and moderate regional LV systolic dysfunction with akinesis of the mid- and distal anterior wall and septum, apex, and distal inferior segment (mid-LAD territory). He was started on ASA, Plavix, BB, and Lisinopril, and was also given nitrates and Imdur. His INR was 3.1 to prevent mural thrombus.

Potential Medical Complications:

1. Cardiac Complications:
	* Recurrent ischemia or infarction due to residual lesions in the LCx and RCA.
	* Thrombus formation in the LV apex due to moderate regional LV systolic dysfunction.
	* Aortic stenosis or regurgitation due to mildly thickened aortic valve leaflets.
2. Hemodynamic Complications:
	* Hypotension or hypertension due to changes in cardiac output or peripheral resistance.
	* Fluid overload or dehydration due to inadequate fluid management.
3. Neurological Complications:
	* Increased risk of stroke or TIA due to hypertension, previous stroke, and anticoagulation therapy.
	* Confusion or disorientation due to medication side effects or electrolyte imbalances.
4. Renal Complications:
	* Acute kidney injury or chronic kidney disease due to hypertension, diabetes, or medication side effects.
	* Increased risk of nephrotoxicity due to the use of nephrotoxic medications.
5. Infection Complications:
	* Ventilator-associated pneumonia (VAP) due to prolonged mechanical ventilation.
	* Catheter-associated urinary tract infection (CAUTI) due to indwelling urinary catheter.
6. Bleeding Complications:
	* Increased risk of bleeding due to anticoagulation therapy, platelet dysfunction, or medication side effects.
	* Hemorrhagic stroke or intracranial hemorrhage due to anticoagulation therapy or hypertension.

It is essential to monitor the patient's condition closely and adjust his treatment plan accordingly to prevent or manage these potential complications."
111738.0,207547,2166-11-08 06:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - CP in AM, followed by increasing CK, peaked at 1147, MB at 113
   - ECHO: moderate regional LV systolic dysfxn with akinesis of the mid-
   and distal anterior wall and septum, apex and distal inferior segment
   (mid-LAD territory). LVEF = 35%
   - wasn't urinating, inserted foley
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2166-11-7**] 09:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-8**] 06:52 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 68 (61 - 100) bpm
   BP: 117/58(72) {85/42(58) - 165/87(104)} mmHg
   RR: 13 (12 - 24) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
                  Total In:
                                                                  2,726 mL
                                                                    120 mL
   PO:
                                                                  1,720 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  1,006 mL
   Blood products:
   Total out:
                                                                    875 mL
                                                                    450 mL
   Urine:
                                                                    875 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,851 mL
                                                                   -330 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///27/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   510 K/uL
   12.2 g/dL
   107 mg/dL
   1.1 mg/dL
   27 mEq/L
   4.4 mEq/L
   20 mg/dL
   106 mEq/L
   140 mEq/L
   36.5 %
   11.1 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
                            [**2166-11-8**]  05:20 AM
   WBC
   10.0
   11.1
   Hct
   37.9
   36.5
   Plt
   [**Telephone/Fax (3) 12094**]
   Cr
   1.0
   1.1
   TropT
   1.00
   2.81
   Glucose
   103
   107
   Other labs: PT / PTT / INR:31.3/30.2/3.1, CK / CKMB /
   Troponin-T:731/44/2.81, Ca++:8.4 mg/dL, Mg++:1.9 mg/dL, PO4:2.6 mg/dL
   Imaging: ECHO:The left atrium is mildly dilated. There is mild
   symmetric left ventricular hypertrophy with normal cavity size. There
   is moderate regional left ventricular systolic dysfunction with
   akinesis of the mid- and distal anterior wall and septum, apex and
   distal inferior segment (mid-LAD territory). The remaining segments
   contract normally (LVEF = 35%). The LV apex is not visualized
   sufficiently for a thrombus to be definitely excluded, although one is
   not seen. Right ventricular chamber size and free wall motion are
   normal. The ascending aorta is mildly dilated. The aortic arch is
   mildly dilated. The aortic valve leaflets (3) are mildly thickened but
   aortic stenosis is not present. No aortic regurgitation is seen. The
   mitral valve leaflets are mildly thickened. Mild (1+) mitral
   regurgitation is seen. There is mild pulmonary artery systolic
   hypertension. There is no pericardial effusion.
   Microbiology: no new micro
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   - will need to discuss with family when intervension of the other
   lesions would be appropriate
   # PUMP: euvolemic on exam
   - restart ACEI
   # RHYTHM: sinus
   - monitor on tele
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   # Dementia: pt at baseline
   - cont home meds
   FEN: Cardiac
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   CODE: FULL- confirmed with wife
   [**Name (NI) **]: Wife: [**Telephone/Fax (1) 12064**]
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) 2351**] and Pride.
   I would add the following remarks:
   Medical Decision Making
   CK peaked overnight at 1147 and the patient has no further chest pain.
   Echo shows mid to distal ant wall and septum are HK with EF 30-35% s/p
   LAD stenting for ASMI. He continue to have significant lesions in the
   LCx and RCA. He is intermittently confused and quite dysarthric. INR is
   3.1 to prevent mural thrombus. For CAD will continue ASA, Plavix, BB
   and Lisinopril 10 mg QD. Will add nitrates and plan to have the patient
   back in 1 month to stent the RCA and LCx. GI prophylaxis for coumadin,
   PLavix and ASA.
   Above discussed extensively with patient. I have discussed this plan
   with Dr(s). [**Name (NI) 2351**] and Pride.
   Total time spent on patient care: 40 minutes of critical care time.
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - CP in AM, followed by increasing CK, peaked at 1147, MB at 113
   - ECHO: moderate regional LV systolic dysfxn with akinesis of the mid-
   and distal anterior wall and septum, apex and distal inferior segment
   (mid-LAD territory). LVEF = 35%
   - wasn't urinating, inserted foley
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2166-11-7**] 09:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-8**] 06:52 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 68 (61 - 100) bpm
   BP: 117/58(72) {85/42(58) - 165/87(104)} mmHg
   RR: 13 (12 - 24) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
                  Total In:
                                                                  2,726 mL
                                                                    120 mL
   PO:
                                                                  1,720 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  1,006 mL
   Blood products:
   Total out:
                                                                    875 mL
                                                                    450 mL
   Urine:
                                                                    875 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,851 mL
                                                                   -330 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///27/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   510 K/uL
   12.2 g/dL
   107 mg/dL
   1.1 mg/dL
   27 mEq/L
   4.4 mEq/L
   20 mg/dL
   106 mEq/L
   140 mEq/L
   36.5 %
   11.1 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
                            [**2166-11-8**]  05:20 AM
   WBC
   10.0
   11.1
   Hct
   37.9
   36.5
   Plt
   [**Telephone/Fax (3) 12094**]
   Cr
   1.0
   1.1
   TropT
   1.00
   2.81
   Glucose
   103
   107
   Other labs: PT / PTT / INR:31.3/30.2/3.1, CK / CKMB /
   Troponin-T:731/44/2.81, Ca++:8.4 mg/dL, Mg++:1.9 mg/dL, PO4:2.6 mg/dL
   Imaging: ECHO:The left atrium is mildly dilated. There is mild
   symmetric left ventricular hypertrophy with normal cavity size. There
   is moderate regional left ventricular systolic dysfunction with
   akinesis of the mid- and distal anterior wall and septum, apex and
   distal inferior segment (mid-LAD territory). The remaining segments
   contract normally (LVEF = 35%). The LV apex is not visualized
   sufficiently for a thrombus to be definitely excluded, although one is
   not seen. Right ventricular chamber size and free wall motion are
   normal. The ascending aorta is mildly dilated. The aortic arch is
   mildly dilated. The aortic valve leaflets (3) are mildly thickened but
   aortic stenosis is not present. No aortic regurgitation is seen. The
   mitral valve leaflets are mildly thickened. Mild (1+) mitral
   regurgitation is seen. There is mild pulmonary artery systolic
   hypertension. There is no pericardial effusion.
   Microbiology: no new micro
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   - will need to discuss with family when intervension of the other
   lesions would be appropriate
   # PUMP: euvolemic on exam
   - restart ACEI
   # RHYTHM: sinus
   - monitor on tele
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   # Dementia: pt at baseline
   - cont home meds
   FEN: Cardiac
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   CODE: FULL- confirmed with wife
   [**Name (NI) **]: Wife: [**Telephone/Fax (1) 12064**]
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) 2351**] and Pride.
   I would add the following remarks:
   Medical Decision Making
   CK peaked overnight at 1147 and the patient has no further chest pain.
   Echo shows mid to distal ant wall and septum are HK with EF 30-35% s/p
   LAD stenting for ASMI. He continue to have significant lesions in the
   LCx and RCA. He is intermittently confused and quite dysarthric. INR is
   3.1 to prevent mural thrombus. For CAD will continue ASA, Plavix, BB
   and Lisinopril 10 mg QD. Will add nitrates and plan to have the patient
   back in 1 month to stent the RCA and LCx. GI prophylaxis for coumadin,
   PLavix and ASA.
   Above discussed extensively with patient. I have discussed this plan
   with Dr(s). [**Name (NI) 2351**] and Pride.
   Total time spent on patient care: 40 minutes of critical care time.<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 88-year-old male with a history of hypertension, stroke, and deep vein thrombosis (DVT) on coumadin, who presented with a ST-segment elevation myocardial infarction (STEMI) and was treated with a bare metal stent (BMS) to the mid-LAD lesion. He has been admitted to the Intensive Care Unit (ICU) for further management.

The patient has experienced chest pain in the morning, which has since resolved. His troponin levels have peaked at 2.81 ng/mL, and his creatine kinase (CK) levels have peaked at 1147 IU/L. An echocardiogram (ECHO) shows moderate regional left ventricular systolic dysfunction with akinesis of the mid- and distal anterior wall and septum, apex, and distal inferior segment, with an ejection fraction (LVEF) of 35%.

The patient has been started on various medications, including aspirin, clopidogrel, lisinopril, and metoprolol, and is being monitored for cardiac rhythm, blood pressure, and oxygen saturation. He has also been prescribed prophylactic measures to prevent deep vein thrombosis (DVT), pulmonary embolism, and stress ulcer.

Potential Medical Complications:

1. Cardiac complications: The patient's cardiac condition is unstable, and there is a risk of further cardiac complications, such as recurrent ischemia, heart failure, or arrhythmias.
2. Renal complications: The patient's creatinine levels are slightly elevated, and there is a risk of further renal deterioration if he is not properly hydrated and monitored.
3. Bleeding complications: The patient is taking anticoagulant medications, including coumadin and clopidogrel, which increase the risk of bleeding complications.
4. Respiratory complications: The patient's oxygen saturation levels are slightly decreased, and there is a risk of respiratory complications, such as pneumonia or acute respiratory distress syndrome (ARDS).
5. Neurological complications: The patient's neurological status is unclear, and there is a risk of further neurological deterioration if he is not properly monitored and managed.
6. Infection complications: The patient is at risk of developing infections, such as pneumonia or sepsis, particularly if he is not properly hydrated and monitored.
7. Gastrointestinal complications: The patient is at risk of developing gastrointestinal complications, such as nausea, vomiting, or bleeding, particularly if he is not properly managed.

Overall, the patient requires close monitoring and management to prevent and address potential medical complications."
111738.0,207547,2166-11-08 06:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - CP in AM, followed by increasing CK, peaked at 1147, MB at 113
   - ECHO: moderate regional LV systolic dysfxn with akinesis of the mid-
   and distal anterior wall and septum, apex and distal inferior segment
   (mid-LAD territory). LVEF = 35%
   - wasn't urinating, inserted foley
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2166-11-7**] 09:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-8**] 06:52 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 68 (61 - 100) bpm
   BP: 117/58(72) {85/42(58) - 165/87(104)} mmHg
   RR: 13 (12 - 24) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
                  Total In:
                                                                  2,726 mL
                                                                    120 mL
   PO:
                                                                  1,720 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  1,006 mL
   Blood products:
   Total out:
                                                                    875 mL
                                                                    450 mL
   Urine:
                                                                    875 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,851 mL
                                                                   -330 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///27/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   510 K/uL
   12.2 g/dL
   107 mg/dL
   1.1 mg/dL
   27 mEq/L
   4.4 mEq/L
   20 mg/dL
   106 mEq/L
   140 mEq/L
   36.5 %
   11.1 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
                            [**2166-11-8**]  05:20 AM
   WBC
   10.0
   11.1
   Hct
   37.9
   36.5
   Plt
   [**Telephone/Fax (3) 12094**]
   Cr
   1.0
   1.1
   TropT
   1.00
   2.81
   Glucose
   103
   107
   Other labs: PT / PTT / INR:31.3/30.2/3.1, CK / CKMB /
   Troponin-T:731/44/2.81, Ca++:8.4 mg/dL, Mg++:1.9 mg/dL, PO4:2.6 mg/dL
   Imaging: ECHO:The left atrium is mildly dilated. There is mild
   symmetric left ventricular hypertrophy with normal cavity size. There
   is moderate regional left ventricular systolic dysfunction with
   akinesis of the mid- and distal anterior wall and septum, apex and
   distal inferior segment (mid-LAD territory). The remaining segments
   contract normally (LVEF = 35%). The LV apex is not visualized
   sufficiently for a thrombus to be definitely excluded, although one is
   not seen. Right ventricular chamber size and free wall motion are
   normal. The ascending aorta is mildly dilated. The aortic arch is
   mildly dilated. The aortic valve leaflets (3) are mildly thickened but
   aortic stenosis is not present. No aortic regurgitation is seen. The
   mitral valve leaflets are mildly thickened. Mild (1+) mitral
   regurgitation is seen. There is mild pulmonary artery systolic
   hypertension. There is no pericardial effusion.
   Microbiology: no new micro
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   - will need to discuss with family when intervension of the other
   lesions would be appropriate
   # PUMP: euvolemic on exam
   - restart ACEI
   # RHYTHM: sinus
   - monitor on tele
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   # Dementia: pt at baseline
   - cont home meds
   FEN: Cardiac
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   CODE: FULL- confirmed with wife
   [**Name (NI) **]: Wife: [**Telephone/Fax (1) 12064**]
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - CP in AM, followed by increasing CK, peaked at 1147, MB at 113
   - ECHO: moderate regional LV systolic dysfxn with akinesis of the mid-
   and distal anterior wall and septum, apex and distal inferior segment
   (mid-LAD territory). LVEF = 35%
   - wasn't urinating, inserted foley
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2166-11-7**] 09:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2166-11-8**] 06:52 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 68 (61 - 100) bpm
   BP: 117/58(72) {85/42(58) - 165/87(104)} mmHg
   RR: 13 (12 - 24) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 72 Inch
                  Total In:
                                                                  2,726 mL
                                                                    120 mL
   PO:
                                                                  1,720 mL
                                                                    120 mL
   TF:
   IVF:
                                                                  1,006 mL
   Blood products:
   Total out:
                                                                    875 mL
                                                                    450 mL
   Urine:
                                                                    875 mL
                                                                    450 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,851 mL
                                                                   -330 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///27/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   510 K/uL
   12.2 g/dL
   107 mg/dL
   1.1 mg/dL
   27 mEq/L
   4.4 mEq/L
   20 mg/dL
   106 mEq/L
   140 mEq/L
   36.5 %
   11.1 K/uL
        [image002.jpg]
                            [**2166-11-6**]  08:26 PM
                            [**2166-11-7**]  03:24 AM
                            [**2166-11-8**]  05:20 AM
   WBC
   10.0
   11.1
   Hct
   37.9
   36.5
   Plt
   [**Telephone/Fax (3) 12094**]
   Cr
   1.0
   1.1
   TropT
   1.00
   2.81
   Glucose
   103
   107
   Other labs: PT / PTT / INR:31.3/30.2/3.1, CK / CKMB /
   Troponin-T:731/44/2.81, Ca++:8.4 mg/dL, Mg++:1.9 mg/dL, PO4:2.6 mg/dL
   Imaging: ECHO:The left atrium is mildly dilated. There is mild
   symmetric left ventricular hypertrophy with normal cavity size. There
   is moderate regional left ventricular systolic dysfunction with
   akinesis of the mid- and distal anterior wall and septum, apex and
   distal inferior segment (mid-LAD territory). The remaining segments
   contract normally (LVEF = 35%). The LV apex is not visualized
   sufficiently for a thrombus to be definitely excluded, although one is
   not seen. Right ventricular chamber size and free wall motion are
   normal. The ascending aorta is mildly dilated. The aortic arch is
   mildly dilated. The aortic valve leaflets (3) are mildly thickened but
   aortic stenosis is not present. No aortic regurgitation is seen. The
   mitral valve leaflets are mildly thickened. Mild (1+) mitral
   regurgitation is seen. There is mild pulmonary artery systolic
   hypertension. There is no pericardial effusion.
   Microbiology: no new micro
   Assessment and Plan
   88 yo M with PMH significant for HTN, h/o stroke [**2156**] and DVT on
   coumadin, dementia presents with STEMI s/p BMS to 80% thrombotic
   mid-LAD lesion.
   # CORONARIES: Pt with anterior STEMI. He was taken to cath and s/p BMS
   to 80% mid LAD lesion. Patient with 80% lesions in ramus and mid RCA
   and a 90% stenosis in a small distal LCx that were not intervened and
   not likely the cause of his CP. TIMI risk score of 5 (12.4% mortality).
   Patient
s recurrent pain concerning for recurrent ischemia, but more
   likely post infarct discomfort
   - ASA 325mg daily
   - cont plavix 75mg daily x 1 year per attending
   - lipitor 80mg daily (LDL 130 per PCP), will also check lipid profile
   - cont BB (will switch to metoprolol 37.5mg TID for easier titration
   during admission given pt was hypertensive)
   - restart lisinopril with holding parameters
   - monitor on tele
   - morphine, nitro gtt, repeat EKG if pain recurs
   - will need to discuss with family when intervension of the other
   lesions would be appropriate
   # PUMP: euvolemic on exam
   - restart ACEI
   # RHYTHM: sinus
   - monitor on tele
   # CRI: Admitted with Creatinine of 1.3 from unclear baseline.  Improved
   to 1.0 today.  Likely chronic given history of HTN.
   - restart lisinopril
   - cont to trend Cr
   - avoid nephrotoxins and renally dose meds
   # h/o DVT: pt reports has had multiple DVT and has been on coumadin
   since his stroke in [**2156**]. INR 2.3
   - cont coumadin at current dose
   - monitor INR goal [**12-31**]
   - T&S
   - monitor Hct given pt is now on ASA, plavix and coumadin
   # Dementia: pt at baseline
   - cont home meds
   FEN: Cardiac
   ACCESS: PIV's
   PROPHYLAXIS:
   -DVT ppx with coumadin
   -Pain management
   -Bowel regimen
   CODE: FULL- confirmed with wife
   [**Name (NI) **]: Wife: [**Telephone/Fax (1) 12064**]
   DISPO: CCU for now
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2166-11-6**] 07:49 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 88-year-old male who was admitted to the ICU with a diagnosis of anterior ST elevation myocardial infarction (STEMI) and underwent percutaneous coronary intervention (PCI) with a bare metal stent (BMS) to an 80% thrombotic mid-LAD lesion. He has a history of hypertension, stroke, and deep vein thrombosis (DVT) for which he is currently taking coumadin.

The patient's current condition is as follows:

* Cardiac: The patient has moderate regional left ventricular systolic dysfunction with akinesis of the mid- and distal anterior wall and septum, apex, and distal inferior segment (mid-LAD territory). The left atrium is mildly dilated, and there is mild symmetric left ventricular hypertrophy with normal cavity size. The patient's left ventricular ejection fraction (LVEF) is 35%.
* Respiratory: The patient is receiving oxygen therapy, and his oxygen saturation is 94%.
* Neurological: The patient's neurological status is not fully assessed due to his dementia and inability to respond to stimuli.
* Renal: The patient's creatinine level has improved from 1.3 to 1.0, and he is restarting lisinopril. His INR is 2.3, and he is on coumadin.
* Hemodynamic: The patient's blood pressure is 117/58 mmHg, and his heart rate is 68 beats per minute.

Potential medical complications that can arise include:

* Cardiac complications: The patient's moderate regional left ventricular systolic dysfunction and akinesis of the mid- and distal anterior wall and septum may lead to further cardiac complications such as heart failure, cardiogenic shock, or arrhythmias.
* Respiratory complications: The patient's mild pulmonary artery systolic hypertension and mild mitral regurgitation may lead to respiratory complications such as pulmonary edema or respiratory failure.
* Renal complications: The patient's history of DVT and current treatment with coumadin may increase his risk of renal complications such as acute kidney injury or chronic kidney disease.
* Neurological complications: The patient's dementia and inability to respond to stimuli may increase his risk of neurological complications such as seizures, stroke, or delirium.
* Hemodynamic complications: The patient's euvolemic status and history of hypertension may lead to hemodynamic complications such as hypotension or hypertension.

Overall, the patient requires close monitoring and management of his cardiac, respiratory, renal, neurological, and hemodynamic status to prevent potential complications and ensure optimal care."
